Three year experience of donor specific transfusion and concomitant cyclosporine a
Hillis, A.N.; Duguid, J.; Evans, C.M.; Bone, J.M.; Sells, R.A.
Transplantation Proceedings 19(1 Part 3): 2248-2249
1987
ISSN/ISBN: 0041-1345 PMID: 2978890 Document Number: 286741
Document emailed within 1 workday
Related Documents
Schulak, J.A.; Cooke, J.C.; Herrmann, M.J. 1990: Failure of donor irradiation and graft lymph node reduction to prolong pancreas allograft survival in cyclosporine- and donor-specific transfusion-treated hosts Transplantation 50(2): 341-343Davies, C.B.; Cofer, B.R.; Alexander, J.W. 1991: Effects of donor-specific transfusion, cyclosporine a and FK 506 on rat cardiac allograft survival Transplantation Proceedings 23(6): 3314-3315
Tchervenkov, J.I.; Epstein, M.D.; Alexander, J.W.; Schroeder, T.J. 1989: The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival Transplantation 47(1): 177-181
Bordes-Aznar, J.; Odor, A.; Dib-Kuri, A.; Gabilondo, F.; Kasep, J.; Peña, J.C.; Herrera-Acosta, J.; Chávez-Peón, F. 1987: Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation Transplantation Proceedings 19(1 Pt 3): 2276-2277
Mottram, P.L.; Mirisklavos, A.; Clunie, G.J. 1985: Cyclosporine and murine responses to alloantigens: effects of cyclosporine and donor-specific transfusions on delayed hypersensitivity reactions and murine skin allografts Transplantation Proceedings 17(2): 1646-1649
Rose, M.; Navarette, C.; Yacoub, M.; Festenstein, H. 1988: Cyclosporine does not abrogate donor-specific class Ii expression in allografted human heart Transplantation Proceedings 20(3 Suppl 3: 333-340
Morad, Z.; Suleiman, A.B.; Kong, C.T. 1989: Hepatitis in renal transplant recipients with and without donor-specific blood transfusion Transplantation Proceedings 21(1 Pt 2): 1825-1826
Choti, M.; Lenrow, D.; Roza, A.; Markmann, J.; Naji, A. 1989: Prolongation of cardiac allograft survival by pretransplant administration of cyclosporine and donor-specific dendritic cells Transplantation Proceedings 21(1 Pt 1): 478-479
Monaco, A.P.; Wood, M.L.; Maki, T.; Hartner, W.; De Fazio, S.; Gozzo, J.J. 1988: Cyclosporine and unresponsiveness to allografts induced by polyclonal antilymphocyte serum and donor-specific bone marrow Transplantation Proceedings 20(3 Suppl 3): 36-48
Oluwole, S.F.; Fawwaz, R.A.; Reemtsma, K.; Hardy, M.A. 1988: The role of suppressor T lymphocytes in the induction of specific immunologic unresponsiveness to rat cardiac allografts by donor leukocytes and cyclosporine Transplantation Proceedings 20(3 Suppl 3: 1038-1044
Greenstein, S.M.; Sun, S.C.; Senitzer, D.; Schechner, R.S.; Tellis, V.A. 1993: Pretreatment with irradiation and donor-specific transfusion prolongs survival in small intestinal transplantation Transplantation Proceedings 25(1 Part 1): 490-491
Gores, P.F.; Sitges-Serra, A.; Hesse, U.J.; Najarian, J.S.; Sutherland, D.E. 1987: Pretransplant transfusion of donor-specific class i major histocompatibility complex antigen in dogs Transplantation Proceedings 19(1 Part 2): 1407-1408
Oluwole, S.F.; Iga, C.; Lau, H.; Hardy, M.A. 1985: Prolongation of rat heart allografts by donor-specific blood transfusion treated with ultraviolet irradiation Journal of Heart Transplantation 4(4): 385-389
Sells, R.A.; Scott, M.H.; Prieto, M.; Bone, J.M.; Evans, G.M.; Millar, R.; Hills, A.N. 1989: Early rejection following donor-specific transfusion prior to HLA-mismatched living related renal transplantation Transplantation Proceedings 21(1 Part 1): 1173-1174
Okazaki, H.; Takahashi, H.; Miura, K.; Ishizaki, M.; Taguchi, Y. 1984: Significant reduction of sensitization and improved allograft outcome with donor-specific buffy coat transfusion Transplantation 37(5): 523-525
al-Muzairai, I.A.; MacLeod, A.M.; Cochrane, S.; Jones, M.C.; Propper, D.; Catto, G.R. 1989: Anti-idiotypic activity in cytotoxic sera from highly sensitised patients (HSP) given cyclosporin A and blood transfusion from a specific donor (ST) Transplantation Proceedings 21(1 Pt 1): 748-749
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1997: Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow Transplantation 63(3): 359-364
Ringers, J.; Haanstra, K.G.; Kroczek, R.A.; Kliem, K.; Kuhn, E.M.; Wubben, J.; Ossevoort, M.A.; Volk, H.Dieter.; Jonker, M. 2002: Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates Transplantation 73(6): 862-866
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1996: Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion Transplantation Proceedings 28(6): 3269
Cicciarelli, J.; Shah, T.; Koss, M.; Houston, K.; Narahghi, R. 2006: Renal graft loss in recipients with at least one year of function and donor specific antibody (DSA) Clinical Transplants 2006: 539-540